Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Byrna Technologies
BYRN
$106M
| $835K | ﹤0.01% |
49,586
| – | – |
|
|
NPB
2902
Northpointe Bancshares
NPB
$597M
| $829K | ﹤0.01% |
+57,426
| New | +$822K |
|
2903
Northeast Community Bancorp
NECB
$374M
| $828K | ﹤0.01% |
35,327
+8
| +0% | +$191 |
|
2904
Vanguard Health Care ETF
VHT
$18.4B
| $828K | ﹤0.01% |
3,127
-785
| -20% | -$209K |
|
2905
Graham Corp
GHM
$1.22B
| $822K | ﹤0.01% |
28,518
+27
| +0.1% | +$1.02K |
|
2906
Getty Images
GETY
$199M
| $822K | ﹤0.01% |
475,034
-52,916
| -10% | -$126K |
|
2907
MaxCyte
MXCT
$115M
| $818K | ﹤0.01% |
299,734
+7,754
| +3% | +$30.6K |
|
2908
Forrester Research
FORR
$226M
| $817K | ﹤0.01% |
88,399
-8,451
| -9% | -$108K |
|
2909
CS Disco
LAW
$260M
| $817K | ﹤0.01% |
199,652
-4,382
| -2% | -$21.3K |
|
2910
Aura Biosciences
AURA
$743M
| $811K | ﹤0.01% |
138,466
| – | – |
|
|
UPB
2911
Upstream Bio Inc
UPB
$367M
| $809K | ﹤0.01% |
132,173
-3,150
| -2% | -$30.1K |
|
2912
Vanguard Financials ETF
VFH
$13.8B
| $808K | ﹤0.01% |
6,764
-1,159
| -15% | -$141K |
|
2913
Atlanticus Holdings
ATLC
$1.67B
| $806K | ﹤0.01% |
15,751
+561
| +4% | +$30.6K |
|
2914
News Corp Class B
NWS
$17.9B
| $804K | ﹤0.01% |
26,468
+13,836
| +110% | +$438K |
|
2915
Bridgewater Bancshares
BWB
$588M
| $803K | ﹤0.01% |
57,814
+2,161
| +4% | +$30.1K |
|
2916
Nice
NICE
$5.82B
| $799K | ﹤0.01% |
5,184
+16
| +0.3% | +$2.56K |
|
|
ESPR
2917
DELISTED
Esperion Therapeutics
ESPR
| $798K | ﹤0.01% |
554,216
| – | – |
|
|
MAZE
2918
Maze Therapeutics
MAZE
$1.54B
| $796K | ﹤0.01% |
+72,305
| New | +$870K |
|
2919
Editas Medicine
EDIT
$422M
| $794K | ﹤0.01% |
684,896
+76,647
| +13% | +$113K |
|
2920
Aldeyra Therapeutics
ALDX
$96.5M
| $793K | ﹤0.01% |
137,985
+1,252
| +0.9% | +$7.4K |
|
2921
Wheels Up
UP
$208M
| $792K | ﹤0.01% |
39,203
-956
| -2% | -$26.3K |
|
2922
Capital Bancorp
CBNK
$611M
| $789K | ﹤0.01% |
27,841
-4
| -0% | -$118 |
|
|
HDSN
2923
Hudson Technologies
HDSN
$262M
| $788K | ﹤0.01% |
127,725
+5,669
| +5% | +$33.3K |
|
|
ARDT
2924
Ardent Health
ARDT
$1.6B
| $787K | ﹤0.01% |
57,255
+28,650
| +100% | +$418K |
|
2925
MeiraGTx Holdings
MGTX
$1.16B
| $787K | ﹤0.01% |
116,027
+4,006
| +4% | +$26.9K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.